Remedium Capital Partners, LLC
13F Portfolio Filings
Most recent 13F Q1 2026Location fort lauderdale, FLCIK 0002104501All SEC filings
Q1 2026 Summary
Quarter | Holdings | VALUE | Top Holdings | Form Type | Date Filed | Filing Id | |
|---|---|---|---|---|---|---|---|
6 | $281.15M | ORUKA THERAPEUTICS INC, SYRE, GALECTO INC, APGE | RESTATEMENT | May 19, 2026 | 000210450126000010 | ||
6 | $171K | SYRE, ORUKA THERAPEUTICS INC, APGE, JADE BIOSCIENCES INC | 13F-HR | Feb 12, 2026 | 000210450126000004 |